SCHEMBL1276010

SCHEMBL1276010

Cc1ccc(OCc2ccc(C(=O)O)cc2)c(Cc2ccc(OCc3ccc(C(=O)O)cc3)c(C=O)c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 4/20 0.50
RXRB P28702 3/20 0.50
RXRG P48443 3/20 0.50
PTGER1 P34995 3/20 0.46
PTGER4 P35408 3/20 0.46
PTGER3 P43115 3/20 0.46
PTGER2 P43116 3/20 0.46
MRGPRX4 Q96LA9 5/20 0.46
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HPGD P15428 1/20 0.44
FOLH1 Q04609 1/20 0.44
TP53 P04637 1/20 0.44
POLB P06746 1/20 0.44
PAX8 Q06710 1/20 0.44
KLF5 Q13887 1/20 0.44
HIF1A Q16665 1/20 0.44
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13718200 0.90 RXRA (0.49) RXRARXRBRXRGMRGPRX4NPC1
SCHEMBL1276478 0.89 MAPT (0.50) PTGER1PTGER4PTGER3PTGER2NPC1
SCHEMBL930474 0.87 MRGPRX4 (0.55) RXRARXRBRXRGMRGPRX4NPC1
SCHEMBL1275782 0.83 PTGDR2 (0.54) PTGER1PTGER4PTGER3PTGER2TP53
SCHEMBL13718412 0.79 LMNA (0.49) NPC1RAB9ASMN1; SMN2HPGDTP53
SCHEMBL1276664 0.79 ALDH1A1 (0.55) RAB9ASMN1; SMN2HPGDPOLBKDM4E
SCHEMBL29955503 0.77 PTGDR2 (0.62) RXRARXRBRXRGMRGPRX4NPC1
SCHEMBL8409609 0.76 PTGER1 (0.62) RXRARXRBRXRGPTGER1PTGER4
SCHEMBL931584 0.76 RXRA (0.59) RXRARXRBRXRGMRGPRX4NPC1
SCHEMBL930595 0.76 MAPT (0.55) NPC1RAB9ASMN1; SMN2HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110028752-A1 NOVEL BIS(FORMYLPHENYL) COMPOUND AND NOVEL POLYNUCLEAR POLYPHENOL COMPOUND DERIVED FROM THE SAME HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2011-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028752-A1 NOVEL BIS(FORMYLPHENYL) COMPOUND AND NOVEL POLYNUCLEAR POLYPHENOL COMPOUND DERIVED FROM THE SAME PAH, PCBP1, MLLT1 RXRA 1729/4885RXRB 1101/4885RXRG 1597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.